Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01568866 |
|---|---|
| Brief Title: | Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients (ENDEAVOR) |
| First Submitted : | March 28, 2012 |
| First Submitted that Met QC Criteria : | March 30, 2012 |
| First Posted : | April 2, 2012 (Estimate) |
| Results First Submitted : | November 6, 2015 |
| Results First Submitted that Met QC Criteria : | November 6, 2015 |
| Results First Posted : | December 11, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | November 10, 2022 |
| Last Update Posted : | November 14, 2022 |